Pharmaceutical News & Resources

Nitto Avecia Pharma Services: API To Clinic Within 4 Months

June 24th, 2019 by aveciapharma

Nitto Avecia Pharma Services, Inc. has a focused vision. We envision each engagement with prospective or long-term clients as an opportunity to deliver innovative ideas that support their mission. Our corporate vision is "Creating Wonders," and we take...

Read Full Story »

Posted in: Outsourced Pharma

A Systematic Approach To Extractables And Leachables: A Review Of Guidance From The Industry

March 28th, 2019 by Aryo A. Nikopour

By Aryo A. Nikopour, Senior Vice President of Scientific and Technical Services, Nitto Avecia Pharma Services Aryo A. Nikopour, Senior Vice President of Scientific and Technical Services with Nitto Avecia Pharma Services, discusses the basic definitions...

Read Full Story »

Posted in: Pharmaceutical Online

Nitto Avecia Pharma Services Addresses Questions About Extractables And Leachables Studies

March 20th, 2019 by Aryo A. Nikopour

By Aryo A. Nikopour, Nitto Avecia Pharma Services Extractable and leachable safety assessments can be some of the most challenging review issues in an FDA application, according to an agency official.1 That is because they require a coordinated...

Read Full Story »

Posted in: Outsourced Pharma

Elemental Impurities Emerge As New Compliance Challenge

March 13th, 2019 by Adam C. Fox

By Adam C. Fox, Senior Vice President, Analytical Operations, Nitto Avecia Pharma Services Why is this service needed? After almost 20 years of discussion, the FDA issued new guidelines in 2018 for controlling and measuring the risk of contamination...

Read Full Story »

Posted in: BioProcess Online, Outsourced Pharma

Extractables And Leachables Studies Support Single-Use Systems

March 12th, 2019 by Aryo A. Nikopour

By Aryo Nikopour, Senior Vice President, Scientific & Technical Services, Nitto Avecia Pharma Services Single-use systems have gained a surprisingly strong foothold in the drug manufacturing market thanks to improved extractables and leachables...

Read Full Story »

Posted in: Pharmaceutical Online

Nitto Avecia Pharma Services Parenteral Manufacturing

March 5th, 2019 by aveciapharma

Nitto Avecia Pharma Services is a FDA inspected cGMP contract development and manufacturing organization supporting the pharmaceutical and biopharmaceutical industries from early phase through post-market life cycle management. With a state-of-the-art...

Read Full Story »

Posted in: Pharmaceutical Online

Why Cell-based Assay Is The Preferred Method To Support Potency Analysis For Biologics

March 4th, 2019 by Aryo A. Nikopour

By Aryo Nikopour, Senior Vice President, Scientific & Technical Services, Nitto Avecia Pharma Services and Ming Li, Ph.D., Principle Scientist and Team Lead in Biopharmaceutical Development, Nitto Avecia Pharma Services Unlike small molecule therapeutics,...

Read Full Story »

Posted in: BioProcess Online

Extractables And Leachables Studies Support Single-Use Systems

February 27th, 2019 by Aryo A. Nikopour

By Aryo Nikopour, Senior Vice President, Scientific & Technical Services, Nitto Avecia Pharma Services Single-use systems have gained a surprisingly strong foothold in the drug manufacturing market thanks to improved extractables and leachables...

Read Full Story »

Posted in: Outsourced Pharma

How To Transfer Cell-based Potency Assays Into A GMP Environment And Maintain Performance

February 25th, 2019 by Aryo A. Nikopour

By Aryo Nikopour, Senior Vice President, Scientific & Technical Services, Nitto Avecia Pharma Services and Ming Li, Ph.D., Principle Scientist and Team Lead in Biopharmaceutical Development, Nitto Avecia Pharma Services Like all living things,...

Read Full Story »

Posted in: BioProcess Online

3 Steps To Better Extractables & Leachables Studies

February 20th, 2019 by Aryo A. Nikopour

By Aryo A. Nikopour, Nitto Avecia Pharma Services There is no shortage of guidance for conducting extractables and leachables studies. For instance, U.S. Pharmacopeia and the Product Quality Research Institute (PQRI) offer separate and useful...

Read Full Story »

Posted in: Outsourced Pharma, Pharmaceutical Online

Nitto Avecia Pharma Services Addresses Questions About Extractables And Leachables Studies

February 14th, 2019 by Aryo A. Nikopour

By Aryo A. Nikopour, Nitto Avecia Pharma Services Extractable and leachable safety assessments can be some of the most challenging review issues in an FDA application, according to an agency official.1 That is because they require a coordinated...

Read Full Story »

Posted in: Pharmaceutical Online

How To Design Cell-based Potency Assays

February 13th, 2019 by Aryo A. Nikopour

By Aryo Nikopour, Senior Vice President, Scientific & Technical Services, Nitto Avecia Pharma Services and Ming Li, Ph.D., Principle Scientist and Team Lead in Biopharmaceutical Development, Nitto Avecia Pharma Services Cell-based potency assays...

Read Full Story »

Posted in: BioProcess Online

Residual Solvents Add Risk To Drug Safety

February 6th, 2019 by Adam C. Fox

By Adam C. Fox, Senior Vice President, Analytical Operations, Nitto Avecia Pharma Services Why is this service needed? Improper detection and removal of residual solvents in raw materials and drug products can cause significant risks to quality...

Read Full Story »

Posted in: Outsourced Pharma

Container/Closure Innovation Delivers New Complexity In Drug Quality

February 5th, 2019 by Adam C. Fox

By Adam C. Fox, Senior Vice President, Analytical Operations, Nitto Avecia Pharma Services Why is this service needed? Many new delivery systems and drug-device combinations make dosing less cumbersome for patients and healthcare providers....

Read Full Story »

Posted in: Pharmaceutical Online

Residual Solvents Testing

February 4th, 2019 by aveciapharma

Assure compliance now with Nitto Avecia Pharma Services’ cost effective identification and quantification of impurities. Nitto Avecia Pharma Services provides expert, rapid analysis of all three classes of residual solvents. Our USP/ICH...

Read Full Story »

Posted in: BioProcess Online

Nitto Avecia Pharma Services Corporate Overview

January 30th, 2019 by aveciapharma

Click here to download Nitto Avecia Pharma Services Corporate Overview brochure....

Read Full Story »

Posted in: Outsourced Pharma

Cell-Based Assays In A GMP Environment: Approaches For Clinical And Commercial Stability Studies

January 23rd, 2019 by Ming Li, Ph.D.

By Ming Li, Ph.D., Principle Scientist & Team Lead, Biopharmaceutical Developmental and Aryo A. Nikopour, SVP of Scientific & Technical Services Dr. Ming Li, Principle Scientist and Team Lead in the Biopharmaceutical Developmental department at Nitto...

Read Full Story »

Posted in: Outsourced Pharma

A Systematic Approach To Extractables And Leachables: A Review Of Guidance From The Industry

January 22nd, 2019 by Aryo A. Nikopour

By Aryo A. Nikopour, Senior Vice President of Scientific and Technical Services, Nitto Avecia Pharma Services Aryo A. Nikopour, Senior Vice President of Scientific and Technical Services with Nitto Avecia Pharma Services, discusses the basic definitions...

Read Full Story »

Posted in: Pharmaceutical Online

Cell-Based Assays in a GMP Environment: Approaches for Clinical and Commercial Stability Studies

January 17th, 2019 by aveciapharma

Potency of biotherapeutics, often determined by cell-based assays, is one of the most important critical quality attributes. Potency must be monitored throughout the entire drug development cycle as it measures drug activity and provides a direct...

Read Full Story »

Posted in: Pharmaceutical Online

A Systematic Approach To Extractables And Leachables: A Review Of Guidance From The Industry

January 16th, 2019 by Aryo A. Nikopour

By Aryo A. Nikopour, Senior Vice President of Scientific and Technical Services, Nitto Avecia Pharma Services Aryo A. Nikopour, Senior Vice President of Scientific and Technical Services with Nitto Avecia Pharma Services, discusses the basic definitions...

Read Full Story »

Posted in: BioProcess Online, Outsourced Pharma

Stability Testing

January 9th, 2019 by aveciapharma

With over 14,000 ft2 storage capacity and over 14 ICH and custom conditions, Nitto Avecia Pharma Services has the capability to help design stability studies tailored to product needs. For the quality control and security your projects demand,...

Read Full Story »

Posted in: BioProcess Online


Back to Top